• Mashup Score: 1

    In a study reported in JAMA Oncology, Darst et al identified germline genetic variants that were associated with increased risk of aggressive vs nonaggressive prostate cancer. As stated by the investigators, “Germline gene panel testing is recommended for men with advanced prostate cancer or a family history of cancer. While evidence is limited for some genes currently included in panel testing, gene panels are also likely to be incomplete and missing genes that influence p rostate cancer risk and

    Tweet Tweets with this article
    • Germline Variants and Risk of Aggressive Prostate Cancer https://t.co/t2u30nfjRv #pcsm #prostatecancer #oncology #genetics